Wed, September 11, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 2, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 27, 2024
[ 12:00 AM ] - WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 10, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 11, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 5, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 16, 2024
[ 12:00 AM ] - WOPRAI
Mon, February 12, 2024
[ 12:00 AM ] - WOPRAI
Tue, January 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, January 3, 2024
[ 12:00 AM ] - WOPRAI
Wed, November 22, 2023
[ 12:00 AM ] - WOPRAI
Tue, November 14, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 10, 2023
[ 12:00 AM ] - WOPRAI
Thu, November 9, 2023
[ 12:00 AM ] - WOPRAI
Fri, October 27, 2023
[ 12:00 AM ] - WOPRAI
Wed, October 25, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 10, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 7, 2023
[ 12:00 AM ] - WOPRAI
Wed, June 7, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 10, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
David Amsellem Downgraded (SUPN) to Hold and Decreased Target to $36 on, Sep 11th, 2024
David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold and Decreased Target from $41 to $36 on, Sep 11th, 2024.
David, nor any peers, have made any analyst calls on SUPN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources